In EGF-stimulated EGFR mutant NSCLC, EGF induced IL-6 secretion, and IL-6, subsequently induced PD-L1 expression through the JAK/STAT3 pathway (55). The gene discussed is IL6; the disease is non-small cell lung carcinoma.